These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 752848)
1. [Value of lymphography in the staging of prostatic cancer]. Proca E; Zamfir V Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1978; 27(6):467-74. PubMed ID: 752848 [No Abstract] [Full Text] [Related]
2. [Lymphatic metastasis in prostatic carcinoma. Diagnostic value of staging and transcutaneous needle biopsy]. Rothenberger K; Hofstetter A; Pfeifer KJ; Voeth C; Pensel J Fortschr Med; 1980 Sep; 98(34):1279-82. PubMed ID: 7461533 [TBL] [Abstract][Full Text] [Related]
3. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer. Staging through laparoscopic lymphadenectomy. Newton M; Moore S; Gaehle KE AORN J; 1994 Apr; 59(4):823-33, 836; quiz 837-40. PubMed ID: 8210240 [No Abstract] [Full Text] [Related]
7. [Prognostic value of clinical staging of prostatic cancer with regard to the degree of histopathological malignancy]. Szymanowski J; Wasilewski A Pol Tyg Lek; 1982 Jul; 37(24-25):709-12. PubMed ID: 7177967 [No Abstract] [Full Text] [Related]
8. [Value of pedal lymphography for staging untreated prostatic carcinoma. Prospective evaluation of pedal lymphography for pretherapeutic staging of prostatic carcinoma (TNM-classification according to the 1974 UICC recommendation)]. Helzel MV; Pfitzenmaier N Rofo; 1982 Oct; 137(4):417-21. PubMed ID: 6216178 [No Abstract] [Full Text] [Related]
9. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. Simon J; Kuefer R; Bartsch G; Volkmer BG; Hautmann RE; Gottfried HW BJU Int; 2008 Aug; 102(4):459-62. PubMed ID: 18325061 [TBL] [Abstract][Full Text] [Related]
10. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158 [TBL] [Abstract][Full Text] [Related]
11. [Prostatic cancer. Reliability of clinical staging and the prognostic significance of age, clinical stage and tumor morphology]. Mihatsch MJ; Rist M; Ohnacker H; Oberholzer M; Spichtin HP; Schmassmann A; Perret A; Torhorst J; Rutishauser G Z Urol Nephrol; 1983 May; 76(5):281-97. PubMed ID: 6880416 [No Abstract] [Full Text] [Related]
12. [Morphology of prostate carcinoma in biopsies and total prostatectomies. Relevance of biopsy findings]. Kastendieck H Pathologe; 1980 Nov; 2(1):31-43. PubMed ID: 7465545 [No Abstract] [Full Text] [Related]
13. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. Cupp MR; Bostwick DG; Myers RP; Oesterling JE J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976 [TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
15. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens. Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059 [TBL] [Abstract][Full Text] [Related]
16. [Postoperative pathomorphologic classification of prostate cancer. Recommendations for the processing of total prostatectomies and relevance of the findings]. Kastendieck H; Hüsselmann H Pathologe; 1982 Sep; 3(5):278-86. PubMed ID: 7145866 [No Abstract] [Full Text] [Related]
17. Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. Forman JD; Lee WR; Roach M; Perez CA; Beyer DC; Blasko JC; Hussey DH; Paryani SB; Pollack A; Potters L; Scardino P; Schellhammer P; Leibel S Radiology; 2000 Jun; 215 Suppl():1373-82. PubMed ID: 11037553 [No Abstract] [Full Text] [Related]
18. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [TBL] [Abstract][Full Text] [Related]
19. The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy? Gingrich JR; Paulson DF Surg Oncol Clin N Am; 1995 Apr; 4(2):335-44. PubMed ID: 7540939 [TBL] [Abstract][Full Text] [Related]
20. Staging of M0 prostatic adenocarcinoma: how aggressive should one be? Olsson CA Prog Clin Biol Res; 1984; 153():455-67. PubMed ID: 6473408 [No Abstract] [Full Text] [Related] [Next] [New Search]